| Melissa Stuart Dillmon, MD | |
|
255 W 5th St Sw, Rome, GA 30165-2817 | |
| (706) 295-3855 | |
| (706) 235-5875 |
| Full Name | Melissa Stuart Dillmon |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 25 Years |
| Location | 255 W 5th St Sw, Rome, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790845071 | NPI | - | NPPES |
| 244483090F | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 054073 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Floyd Medical Center | Rome, GA | Hospital |
| Redmond Regional Medical Center | Rome, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Harbin Clinic Llc | 0446154231 | 264 |
News Archive
The liver is unique among mammalian organs in its ability to regenerate after significant tissue damage or even partial surgical removal. Laurie DeLeve and her colleagues at the University of Southern California in Los Angeles wanted to better understand which cells are specifically responsible for driving liver regeneration.
A variation in a gene involved in regulating cholesterol in the bloodstream also appears to affect progesterone production in women, making it a likely culprit in a substantial number of cases of their infertility, a new study from Johns Hopkins researchers suggests.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
Signostics Inc., a U.S. and Australian-based medical device company developing revolutionary and affordable palm-sized ultrasound devices, has raised $5 million in an oversubscribed round of financing from new and existing investors. The company has raised a total of $19 million to date.
The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs.
› Verified 3 days ago
| Entity Name | Harbin Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679599088 PECOS PAC ID: 0446154231 Enrollment ID: O20031124000117 |
News Archive
The liver is unique among mammalian organs in its ability to regenerate after significant tissue damage or even partial surgical removal. Laurie DeLeve and her colleagues at the University of Southern California in Los Angeles wanted to better understand which cells are specifically responsible for driving liver regeneration.
A variation in a gene involved in regulating cholesterol in the bloodstream also appears to affect progesterone production in women, making it a likely culprit in a substantial number of cases of their infertility, a new study from Johns Hopkins researchers suggests.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
Signostics Inc., a U.S. and Australian-based medical device company developing revolutionary and affordable palm-sized ultrasound devices, has raised $5 million in an oversubscribed round of financing from new and existing investors. The company has raised a total of $19 million to date.
The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Stuart Dillmon, MD 221 Technology Pkwy Nw, Rome, GA 30165-1369 Ph: (762) 235-1000 | Melissa Stuart Dillmon, MD 255 W 5th St Sw, Rome, GA 30165-2817 Ph: (706) 295-3855 |
News Archive
The liver is unique among mammalian organs in its ability to regenerate after significant tissue damage or even partial surgical removal. Laurie DeLeve and her colleagues at the University of Southern California in Los Angeles wanted to better understand which cells are specifically responsible for driving liver regeneration.
A variation in a gene involved in regulating cholesterol in the bloodstream also appears to affect progesterone production in women, making it a likely culprit in a substantial number of cases of their infertility, a new study from Johns Hopkins researchers suggests.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
Signostics Inc., a U.S. and Australian-based medical device company developing revolutionary and affordable palm-sized ultrasound devices, has raised $5 million in an oversubscribed round of financing from new and existing investors. The company has raised a total of $19 million to date.
The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs.
› Verified 3 days ago
Dr. Jeffrey Todd Talbot, MD, MPH Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 501 Redmond Rd Nw, Rome, GA 30165 Phone: 404-502-5778 | |
Robert John Madden, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 14 John Maddox Dr Nw, Rome, GA 30165 Phone: 706-295-7320 Fax: 706-295-7319 | |
Dr. Susan Uchenna Otaluka, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 304 Turner Mccall Blvd Sw, Rome, GA 30165 Phone: 706-509-5000 | |
Dr. Nicole Lauren Gilreath, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 304 Turner Mccall Blvd, Rome, GA 30165 Phone: 706-509-5000 | |
Pamela D Shannon, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 315 West 10th Street, Ste 110 Affordable Health Care Llc, Rome, GA 30165 Phone: 706-802-1322 Fax: 706-802-0716 | |
Mrs. Anna-belle Marie Robertson, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 123 Three Rivers Dr Ne, Rome, GA 30161 Phone: 706-295-3961 | |
Dr. Hamid Reza Chimeh, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 20 Riverbend Dr Sw, Rome, GA 30161 Phone: 706-378-7661 Fax: 706-378-7663 |